English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [847]
News [2149]
Articles [24]
Editorials [1]
Conferences [133]
elearning [2]
The importance of big data for blood cancer
Prof Ken Mills - Queen's University of Belfast, UK, HARMONY Associated Member
The importance of big data for blood cancer ( Prof Ken Mills - Queen's University of Belfast, UK, HARMONY Associated Member )
26 Nov 2018
Can we cure advanced metastatic melanoma patients?
Prof Axel Hauschild - University Hospital, Schleswig-Holstein. Germany
Can we cure advanced metastatic melanoma patients? ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein. Germany )
22 Nov 2018
Will computers replace the dermatologist?
Dr Susanna Puig - Hospital Clínic de Barcelona, Barcelona, Spain
Will computers replace the dermatologist? ( Dr Susanna Puig - Hospital Clínic de Barcelona, Barcelona, Spain )
22 Nov 2018
Molecular stratification of melanoma and the high burden of mutations
Dr Joan Anton Puig Butille - Hospital Clínic de Barcelona, Barcelona, Spain
Molecular stratification of melanoma and the high burden of mutations ( Dr Joan Anton Puig Butille - Hospital Clínic de Barcelona, Barcelona, Spain )
22 Nov 2018
Editor’s Choice for October 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for October 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
1 Nov 2018
Dosing regiment in the combination of ipilimumab and nivolumab in stage III...
Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma ( Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands )
29 Oct 2018
Anti–PD-L1 atezolizumab or chemotherapy as second-line therapy in patients with...
Prof Jean-Louis Pujol - CHRU de Montpellier, Hôpital Arnaud de Villeneuve...
Anti–PD-L1 atezolizumab or chemotherapy as second-line therapy in patients with SCLC ( Prof Jean-Louis Pujol - CHRU de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France )
26 Oct 2018
The Circulating Cell-Free Genome Atlas Study
Dr Minetta C. Liu - Mayo Clinic, Rochester, Minessota
The Circulating Cell-Free Genome Atlas Study ( Dr Minetta C. Liu - Mayo Clinic, Rochester, Minessota )
25 Oct 2018
Liquid biopsy as a monitoring tool for the benefit of chemotherapy...
Dr Laura Bonanno - University of Padova, Padova, Italy
Liquid biopsy as a monitoring tool for the benefit of chemotherapy-immunotherapy in aNSCLC ( Dr Laura Bonanno - University of Padova, Padova, Italy )
24 Oct 2018
PEACE: Collecting cancer tissue to solve the riddle of metastasis
Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK
PEACE: Collecting cancer tissue to solve the riddle of metastasis ( Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK )
21 Oct 2018
Latest concepts in the diagnosis of genetic ALL subtypes
Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Latest concepts in the diagnosis of genetic ALL subtypes ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
18 Oct 2018
Management of MLL-rearranged ALL
Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht...
Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )
18 Oct 2018
<1…4041424344…71>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top